The relationship between palmitoyl-coenzyme A synthetase activity and esterification of sn-glycerol 3-phosphate by the microsomal fraction of guinea-pig intestinal mucosa.
1. With microsomal fractions of guinea-pig intestinal mucosa the mean specific activity of palmitoyl-CoA synthetase was approx. 1.3-fold the esterification of sn-glycerol 3-phosphate with palmitoyl-CoA generated by the endogenous synthetase. The latter activity was approx. 2.5- and 5-fold that when palmitoyl-CoA was generated from palmitoylcarnitine or when it was added directly to the assay system. 2. There were significant correlations (P<0.001) between the specific activities of palmitoyl-CoA synthetase and glycerolipid synthesis from either palmitate or palmitoylcarnitine. 3. The mean molar composition of glycerolipid synthesized from palmitate or palmitoylcarnitine was approx. 18% lysophosphatidate, 75% phosphatidate and 7% neutral lipid. 4. Glycerolipid synthesis from palmitate was inhibited by 80-90% after preincubation of microsomal fractions at 37 degrees C for 40min and was caused by inactivation of palmitoyl-CoA synthetase. 5. Addition of 100-400mm-KCl inhibited palmitoyl-CoA synthetase activity and glycerolipid synthesis from palmitate but stimulated glycerol phosphate acyltransferase activity. 6. Diversion of palmitoyl-CoA synthesized by the endogenous synthetase to palmitoylcarnitine resulted in an almost stoicheiometric decrease in glycerolipid synthesis. 7. Addition of rac-1-monopalmitin promoted utilization of palmitoyl-CoA by the monoglyceride pathway but did not inhibit phosphatidate biosynthesis. 8. With rate-limiting concentrations of CoA and Mg(2+) the relative decreases in velocity for palmitoyl-CoA synthetase and glycerolipid synthesis from palmitate were almost identical. However, low concentrations of palmitate and ATP produced greater decreases in synthetase activity than in glycerolipid synthesis. 9. There appears to be a fine balance between the activities of palmitoyl-CoA synthetase and glycerol phosphate acyltransferase, with neither activity being in excess with respect to phosphatidate synthesis.
D000217:Acyltransferases / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D002331:Carnitine / Q000378:metabolism; D003066:Coenzyme A Ligases / Q000378:metabolism*; D005989:Glycerides / Q000494:pharmacology; D005994:Glycerophosphates / Q000378:metabolism*; D006168:Guinea Pigs; D007413:Intestinal Mucosa / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D007421:Intestine, Small / Q000201:enzymology; D007700:Kinetics; D008297:Male; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology*; D010169:Palmitic Acids / Q000378:metabolism / Q000494:pharmacology; D010743:Phospholipids / Q000096:biosynthesis; D011189:Potassium Chloride / Q000494:pharmacology; D013347:Subcellular Fractions / Q000201:enzymology; D013997:Time Factors; D014316:Tritium
D002247:Carbon Isotopes; D005989:Glycerides; D005994:Glycerophosphates; D010169:Palmitic Acids; D010743:Phospholipids; D014316:Tritium; D011189:Potassium Chloride; D000217:Acyltransferases; D003066:Coenzyme A Ligases; D002331:Carnitine